Tit for tat posts on HC have no effect on sp’s but I do enjoy reading them.
Longer winded, more professional posts may influence readers but the motivation behind them is always suspect.
A 76m cap company is always more likely to benefit holders with a TO offer than a 2bn co.
Stem cell companies are disruptive atm so history of sp movement is not relevant to me.
Low risk with CYP is why I am in.
All imo.
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-183
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $40.65M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 22.5¢ | $23.03K | 102.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17986 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 49931 | 1 |
View Market Depth
| Last trade - 15.49pm 16/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |